The novel therapy of tirzepatide peptide represents a major breakthrough in the management of type 2 diabetes. Unlike existing medications, tirzepatide affects two pathways – glucagon-like peptide-1 (GLP-1) and the https://tirzepatidepeptide193692.tribunablog.com/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment-56734080